Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kyle Stephenson

Orthopaedic Surgery Anderson, IN Doctor of Osteopathy

NPI 1750647608 CMS profile 2792691

3125 S Scatterfield Rd Ste 210, Anderson, IN 46013

Open in the dashboard

General payments

$23,475

159 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kyle Stephenson of Anderson, IN is reported in the CMS Open Payments database as having received $23,475 across 159 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 82nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $264 12
2024 General $2,469 28
2023 General $400 12
2022 General $5,727 21
2021 General $4,709 27
2020 General $3,018 18
2019 General $6,887 41

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kyle Stephenson
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Kyle Stephenson were reported at $264. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Kyle Stephenson Orthopaedic Surgery median Middle half National median
2019 $6,887 $644 $140–$2,844 $163
2020 $3,018 $312 $75–$1,860 $114
2021 $4,709 $520 $117–$2,495 $132
2022 $5,727 $598 $128–$2,731 $149
2023 $400 $461 $128–$2,264 $160
2024 $2,469 $497 $134–$2,475 $164
2025 $264 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Crossroads Orthopedics, LLC $8,570 30 payments
  2. Peerless Surgical Inc. $3,826 9 payments
  3. Stryker Corporation $3,568 31 payments
  4. Arthrex, Inc. $2,746 16 payments
  5. Encore Medical, LP $1,815 13 payments
  6. Smith+Nephew, Inc. $1,638 15 payments
  7. DePuy Synthes Sales Inc. $268 5 payments
  8. Acumed LLC $189 2 payments
  9. Avanos Medical $159 3 payments
  10. Orthofix Medical, Inc. $147 9 payments
  11. Other $549 26 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $10,132 9 payments
  2. Travel and Lodging $7,713 30 payments
  3. Food and Beverage $5,630 120 payments
Products named General payments · program years 2019–2025
  1. HIP ARTHROSCOPY ACCESS & INSTRUMENTATION SET $2,102 10 payments
  2. Bone Anchors with Arthroscopic Delivery System $1,407 6 payments
  3. DJO SURGICAL $598 7 payments
  4. DJO Surgical AltiVate Anatomic System $546 2 payments
  5. DJO Surgical Empowr Knee System $524 3 payments
  6. DJO Surgical AltiVate Reverse $295 2 payments
  7. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $166 1 payment
  8. ON-Q* PUMP AND ACCESSORIES $159 3 payments
  9. MAKO $150 1 payment
  10. COBRA $149 1 payment
  11. Other $3,887 87 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

22

Median for Orthopedic Surgery: 203

Drug cost

$28

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 22 $28

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 50 billing codes

Paid by Medicare

$69,508

Of which drugs: $20,962

Medicare patients

152

Average age 74

Services billed

2,175

86 women, 66 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 31%
Depression 30%
Diabetes 28%
Chronic kidney disease 28%
COPD 14%
Atrial fibrillation 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg J3304 Office 13 1,156 $16,038
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 58 353 $277

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

159 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record